Eating disorders arise from a complex interaction of biological, psychological, and environmental factors. Twin and family studies estimate the heritability of anorexia and bulimia at 50 to 80 percent, suggesting a strong genetic predisposition that interacts with life experience to trigger illness onset, most commonly during adolescence or young adulthood.
Brain imaging research consistently shows altered serotonin and dopamine signaling in patients with eating disorders, particularly in regions governing reward, impulse control, and interoceptive awareness. According to the National Eating Disorders Association, these neurobiological differences help explain why the illness feels so consuming and why willpower alone cannot resolve it.
Sociocultural pressure, perfectionism, history of trauma, weight-related teasing, and co-occurring conditions like anxiety, depression, OCD, or ADHD further increase risk. Innovative neuromodulation tools such as TMS therapy with ExoMind, which is FDA-cleared specifically for binge eating disorder, target these underlying brain circuits to support recovery.
